<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02843724</url>
  </required_header>
  <id_info>
    <org_study_id>CanadianCNN</org_study_id>
    <nct_id>NCT02843724</nct_id>
  </id_info>
  <brief_title>Integrative Care for Type 2 Diabetes</brief_title>
  <official_title>Integrative Care for Type 2 Diabetes: Evaluating the Impact of Naturopathic Adjunctive Care for Diabetic Patients of a Family Health Team</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Canadian College of Naturopathic Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Canadian College of Naturopathic Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A two year, two arm pragmatic trial to investigate the integration of naturopathic care with
      conventional medical care to provide additional benefit beyond that of conventional medical
      care alone in achieving adequate control of diabetes.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">July 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinically meaningful reduction of HbA1c above and beyond that of control arm</measure>
    <time_frame>1 year</time_frame>
    <description>To assess the integration of naturopathic care to conventional medical care in obtaining a clinically meaningful reduction of HbA1c (equal or &gt; 0.5%) above and beyond reduction of HbA1c in the control group of phase 1 at 52 week for participants from Wise Elephant Family Health Team (WE-FHT) with type 2 diabetes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of metabolic syndrome</measure>
    <time_frame>2 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight (as part of BMI)</measure>
    <time_frame>2 year</time_frame>
    <description>Kg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Height (as part of BMI)</measure>
    <time_frame>2 year</time_frame>
    <description>meters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Waist circumference (as part of metabolic syndrome)</measure>
    <time_frame>2 year</time_frame>
    <description>inches</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fasting blood glucose</measure>
    <time_frame>2 year</time_frame>
    <description>Fasting glucose (FG), biomarker associated with diabetes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glycated hemoglobin (HbA1c)</measure>
    <time_frame>2 year</time_frame>
    <description>Biomarker associated with diabetes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure (BP)</measure>
    <time_frame>2 year</time_frame>
    <description>Systolic and diastolic blood pressure, seated, resting</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total cholesterol (TC) (blood)</measure>
    <time_frame>2 year</time_frame>
    <description>Biomarkers associated with cholesterol &amp; cardiovascular risk</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>High-density lipoprotein (HDL-C) (blood)</measure>
    <time_frame>2 year</time_frame>
    <description>Biomarkers associated with cholesterol &amp; cardiovascular risk</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Low-density lipoprotein (LDL-C) (blood)</measure>
    <time_frame>2 year</time_frame>
    <description>Biomarkers associated with cholesterol &amp; cardiovascular risk</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Triglycerides (TG))(blood)</measure>
    <time_frame>2 year</time_frame>
    <description>Biomarkers associated with cholesterol &amp; cardiovascular risk</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>High-sensitivity C-reactive protein (hs-CRP)</measure>
    <time_frame>2 year</time_frame>
    <description>Biomarker associated with cardiovascular risk</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of smoking</measure>
    <time_frame>2 year</time_frame>
    <description>Modifiable risk factors for cardiovascular disease</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of obesity</measure>
    <time_frame>2 year</time_frame>
    <description>Modifiable risk factors for cardiovascular disease, BMI equal to or greater than 30.0 kg/m2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of depression (PHQ-9)</measure>
    <time_frame>2 year</time_frame>
    <description>Depression as defined by the PHQ-9</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impact on stress, anxiety, quality of life</measure>
    <time_frame>2 year</time_frame>
    <description>ADDQol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impact on anxiety</measure>
    <time_frame>2 year</time_frame>
    <description>GAD 7</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>DES</measure>
    <time_frame>2 year</time_frame>
    <description>Impact on quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF-12</measure>
    <time_frame>2 year</time_frame>
    <description>Impact on quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compliance/adherence with treatment prescriptions including changes in lifestyle, diet, exercise, and nutraceutical supplementation</measure>
    <time_frame>2 year</time_frame>
    <description>Diet and physical activity tracker</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compliance/adherence with pharmaceutical prescriptions using a medication adherence questionnaire</measure>
    <time_frame>2 year</time_frame>
    <description>MMAQ</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>2 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">148</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <arm_group>
    <arm_group_label>Control (Conventional) Arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Treatment of Type 2 Diabetes according to the Canadian Diabetes Association guidelines. Participants' other health concerns to be addressed as per usual care by practitioners at Wise-Elephant Family Health Team.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Integrative (Naturopathic + Conventional) Arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In addition to conventional care, participants will receive free naturopathic care at Brampton Naturopathic Teaching Clinic (located within the Brampton Civic Hospital). Senior student clinicians will provide care under the direct supervision of licensed naturopathic doctors. A naturopathic menu of treatment options have been designed to reflect naturopathic practice and vetted by 3 licensed naturopathic doctors and experts in the field. Participants' other health concerns will be addressed as per naturopathic doctors' discretion.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Naturopathic Care</intervention_name>
    <description>Naturopathic diabetes care will be selected from a pre-approved menu. Participants' other health concerns will be addressed at naturopathic doctors' discretion</description>
    <arm_group_label>Integrative (Naturopathic + Conventional) Arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Usual (Conventional) Care</intervention_name>
    <description>2016 Canadian Diabetes Clinical Practice Guidelines (self-management, blood-glucose-lowering, vascular protection, pharmacotherapy) will be implemented</description>
    <arm_group_label>Control (Conventional) Arm</arm_group_label>
    <arm_group_label>Integrative (Naturopathic + Conventional) Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males or females, enrolled as a patient with WE-FHT

          -  Ages 21-75 years old

          -  Diagnosed with type 2 diabetes and not adequately controlled (HbA1c &gt; 7.0mmol/L)

          -  Currently seeking care with a medical doctor, nurse practitioner and/or physician
             assistant

          -  Willingness to adhere to randomized treatment with availability for follow-up

          -  Ability to answer self- and interviewer- administered questions in English or have an
             English speaking caregiver who can aid in answering self- and interviewer-
             administered questions

          -  Ability to provide written informed consent or give informed consent through
             substitute decision maker

          -  Capacity to maintain a diary and log of treatments and recommendations given during
             study

        Exclusion Criteria:

          -  Lacking capacity for consent

          -  Pregnancy or an intention to become pregnant in the following two years

          -  Breastfeeding

          -  History of myocardial infarction within the past 6 months

          -  Chronic kidney (eGFR &lt;30 mL/min) or liver disease

          -  Actively receiving care from a complex care diabetes clinic

          -  History of severe hypoglycemia in the last year resulting in hospital emergency care
             [where hypoglycemia is defined to be: 1) development of autonomic or neuroglycopenic
             symptoms, 2) low plasma glucose level (&lt;4.0mmol/L for patients treated with insulin or
             an insulin secretagogue) and 3) symptoms responding to the administration of
             carbohydrate] or hypoglycemia unawareness

          -  Current bolus or pre-mixed insulin treatment

          -  Limited life expectancy (&lt; 6 months)

          -  High level of functional dependency (inability to perform common activities of daily
             living)

          -  In participants aged 65yoa to 75yoa, the following also serve as exclusion criteria:

               1. Recent MI or stroke (within last 6 months)

               2. NYHA CHF Functional Capacity Stage III or above

               3. NYHA CHF Objective Assessment Stage C or greater
                  (http://www.heart.org/HEARTORG/Conditions/HeartFailure/AboutHeartFailure/Classes-
                  of-Heart-Failure_UCM_306328_Article.jsp)

               4. Planned revascularization procedure (PCI or coronary artery bypass graft) or
                  coronary angiogram within 90 days after screening or randomization
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ellen Wong, ND</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Canadian College of Naturopathic Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ellen Wong, ND</last_name>
    <phone>416-498-1255</phone>
    <phone_ext>303</phone_ext>
    <email>ewong@ccnm.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kieran Cooley, ND</last_name>
    <phone>416-498-1255</phone>
    <phone_ext>324</phone_ext>
    <email>kcooley@ccnm.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Wise Elephant Family Health Team</name>
      <address>
        <city>Brampton</city>
        <state>Ontario</state>
        <zip>L6V 4H4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sanjeev Goel, MD</last_name>
      <phone>(289) 323-0660</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Canadian College of Naturopathic Medicine</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M2K 1E2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 14, 2016</study_first_submitted>
  <study_first_submitted_qc>July 21, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 26, 2016</study_first_posted>
  <last_update_submitted>July 21, 2016</last_update_submitted>
  <last_update_submitted_qc>July 21, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Canadian College of Naturopathic Medicine</investigator_affiliation>
    <investigator_full_name>Ellen Wong</investigator_full_name>
    <investigator_title>Co Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Uncontrolled Type 2 Diabetes</keyword>
  <keyword>HbA1c &gt;7.0%</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

